Pietro Spagnolo

Dr. Pietro Spagnolo

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2023 in European Journal of Preventive Cardiology
Verified
Journal Article
Closed access
PDF file
AMAlexis Elias Malavazos
Alexis Elias Malavazos
Gianluca IacobellisGianluca Iacobellis
Gianluca Iacobellis
EDElena Dozio
Elena Dozio
Sara BasilicoSara Basilico
Sara Basilico
AVAngelica Di Vincenzo
Angelica Di Vincenzo
ENEnzo Nisoli
Enzo Nisoli
Aims: Human epicardial adipose tissue (EAT) plays a crucial role in the development and progression of coronary artery disease, atrial fibrillation, and heart failure. Microscopically, EAT is composed of adipocytes, nerve tissues, inflammatory, stromovascular, and immune cells. Epicardial adipose tissue is a white adipose tissue, albeit it also has brown fat-like or beige fat-like features. No muscle fascia divides EAT and myocardium; this allows a direct interaction and crosstalk between the epicardial fat and the myocardium. Thus, it might be a therapeutic target for pharmaceutical compounds acting on G-protein–coupled receptors, such as those for glucose-dependent insulinotropic polypeptide (GIP), glucagon (GCG), and glucagon-like peptide-1 (GLP-1), whose selective stimulation with innovative drugs has demonstrated beneficial cardiovascular effects. The precise mechanism of these novel drugs and their tissue and cellular target(s) need to be better understood. We evaluate whether human EAT expresses GIP, GCG, and GLP-1 receptors and whether their presence is related to EAT transcriptome. We also investigated protein expression and cell-type localization specifically for GIP receptor (GIPR) and glucagon receptor (GCGR). Methods and results: Epicardial adipose tissue samples were collected from 33 patients affected by cardiovascular diseases undergoing open heart surgery (90.9% males, age 67.2 ± 10.5 years mean ± SD). Microarray and immunohistochemistry analyses were performed. Microarray analysis showed that GIPR and GCGR messenger ribonucleic acids (mRNAs) are expressed in EAT, beyond confirming the previously found GLP-1 [3776 ± 1377 arbitrary unit (A.U.), 17.77 ± 14.91 A.U., and 3.41 ± 2.27 A.U., respectively]. The immunohistochemical analysis consistently indicates that GIPR and GCGR are expressed in EAT, mainly in macrophages, isolated, and in crown-like structures. In contrast, only some mature adipocytes of different sizes showed cytoplasmic immunostaining, similar to endothelial cells and pericytes in the capillaries and pre-capillary vascular structures. Notably, EAT GIPR is statistically associated with the low expression of genes involved in free fatty acid (FFA) oxidation and transport and those promoting FFA biosynthesis and adipogenesis (P < 0.01). Epicardial adipose tissue GCGR, in turn, is related to genes involved in FFA transport, mitochondrial fatty acid oxidation, and white-to-brown adipocyte differentiation, in addition to genes involved in the reduction of fatty acid biosynthesis and adipogenesis (P < 0.01). Conclusions: Having reported the expression of the GLP-1 receptor previously, here, we showed that GIPR and GCGR similarly present at mRNA and protein levels in human EAT, particularly in macrophages and partially adipocytes, suggesting these G-protein–coupled receptors as pharmacological targets on the ongoing innovative drugs, which seem cardiometabolically healthy well beyond their effects on glucose and body weight.

16 December 2009 in La radiologia medica
Verified
Journal Article
Closed access
PDF file
EMErica Maffei
Erica Maffei
APA. Palumbo
A. Palumbo
Chiara MartiniChiara Martini
Chiara Martini
WMW. Meijboom
W. Meijboom
CTC. Tedeschi
C. Tedeschi
Filippo CademartiriFilippo Cademartiri
Filippo Cademartiri

15 December 2025 in European Heart Journal - Quality of Care and Clinical Outcomes
Verified
Journal Article
Closed access
ACAntonia Camporeale
Antonia Camporeale
GGGianluigi Guida
Gianluigi Guida
MPMaurizio Pieroni
Maurizio Pieroni
FPFederico Pieruzzi
Federico Pieruzzi
PLPaola Lusardi
Paola Lusardi
MLMassimo Lombardi
Massimo Lombardi
Aims: Limited data exist about the prognostic significance of the processes underlying Fabry Disease (FD) cardiomyopathy (storage, hypertrophy, inflammation/fibrosis) as detected by cardiac magnetic resonance (CMR). Notably, T1 mapping has had limited prognostic application primarily due to poor reproducibility across different sequences and vendors. This CMR study aimed to identify the prognostic weight of the different mechanisms of FD cardiomyopathy and to develop a predictive score of adverse cardiovascular (CV) events. Methods and results: This prospective, observational study enrolled 167 FD patients, who underwent CMR at baseline. The study endpoint was the composite of all-cause death, heart failure hospitalization, new-onset atrial fibrillation/flutter, non-sustained/sustained ventricular tachycardia, major bradyarrhythmias, and myocardial infarction with non-obstructive coronary arteries. Over a median follow-up of 40 months, 27 patients (16%) experienced the primary endpoint. Left ventricle mass index (LVMI) [HR 1.02 (1.02–1.03), P < 0.001], presence of late gadolinium enhancement (LGE) [HR 20.12 (6.02–67.24), P < 0.001] and its extent [number of LGE + segments: HR 1.51 (1.33–1.71), P < 0001], and septal T1 [HR 0.98 (0.97–0.99), <0.001], measured in both ShMOLLI and MOLLI sequences, were associated with the composite endpoint. None of the patients with normal T1 experienced adverse CV events. A multivariable model including age, LVMI, number of LGE+ segments, and T1 value showed a good performance in predicting the composite endpoint. Conclusion: We propose a 3-year prognostic score to predict CV outcome in FD, including age, LVMI, number of LGE+ segments, and septal T1. Normal T1 has a negative predictive value for adverse CV events irrespective of the acquisition setting.

21 February 2024 in European Journal of Preventive Cardiology
Verified
Journal Article
Closed access
PDF file
AAAndrea Attanasio
Andrea Attanasio
LTLara Tondi
Lara Tondi
SCserenella castelvecchio
serenella castelvecchio
VPVittorio Pazzanese
Vittorio Pazzanese
APAnna Palmisano
Anna Palmisano
PCPaolo G Camici
Paolo G Camici
Andrea Attanasio, Lara Tondi, Serenella Castelvecchio, Vittorio Pazzanese, Anna Palmisano, Antonio Esposito, Pietro Ameri, Claudia Canale, Alberto Cappelletti,

Verified
Journal Article
Open access
PDF file
Emanuele MicaglioEmanuele Micaglio
Emanuele Micaglio
LTLara Tondi
Lara Tondi
SBSara Benedetti
Sara Benedetti
MSMaria Alessandra Schiavo
Maria Alessandra Schiavo
ACAntonia Camporeale
Antonia Camporeale
MLMassimo Lombardi
Massimo Lombardi
PRKAG2 cardiomyopathy is a rare genetic disorder that manifests early in life with an autosomal dominant inheritance pattern. It harbors left ventricular hypertrophy (LVH), ventricular pre-excitation and progressively worsening conduction system defects. Its estimated prevalence among patients with LVH ranges from 0.23 to about 1%, but it is likely an underdiagnosed condition. We report the association of the PRKAG2 missense variant c.1006G>A p. (Val336Ile) with LVH, conduction abnormalities (short PR interval and incomplete right bundle branch bock) and early-onset arterial hypertension (AH) in a 44-year-old Caucasian patient. While cardiac magnetic resonance (CMR) showed a mild hypertrophic phenotype with maximal wall thickness of 17 mm in absence of tissue alterations, the electric phenotype was relevant including brady–tachy syndrome and recurrent syncope. The same variant has been detected in the patient’s sister and daughter, with LVH + early-onset AH and electrocardiographic (ECG) alterations + lipothymic episodes, respectively. Paying close attention to the coexistence of LVH and ECG alterations in the proband has been helpful in directing genetic tests to exclude primary cardiomyopathy. Hence, identifying the genetic basis in the patient allowed for familial screening as well as a proper follow-up and therapeutic management of the affected members. A review of the PRKAG2 cardiomyopathy literature is provided alongside the case report.

18 March 2025 in Bioengineering
Verified
Journal Article
Open access
PDF file
ASAlessandra Sala
Alessandra Sala
CVCarlo De Vincentiis
Carlo De Vincentiis
FGFrancesco Grimaldi
Francesco Grimaldi
BRBarbara Rubino
Barbara Rubino
MCManuela Cirami
Manuela Cirami
PSPietro Spagnolo
Pietro Spagnolo
Background: Surgical indication of ascending thoracic aortic aneurysms (ATAA) is generally performed in prevention. Guidelines use aortic diameter as a predictor of rupture and dissection; however, this single parameter alone has a limited value in predicting the real-world risk of acute aortic syndromes. The novel photon-counting CT scan(pc-CT) is capable of better-analyzing tissue composition and aortic characterization. The aim of the study is to assess whether the correlation between aortic wall thickness measured with a pc-CT scan and histology exists. Methods: 14 Patients, with a mean age of 47 years, undergoing cardiac surgery for ATAA, who had preoperatively undergone a pc-CT scan, were retrospectively analyzed. Histology analyses of the resected aortic wall aneurysm were reviewed, and minimum/maximum measurements of intima+media of the aortic wall were performed. Radiology images were also examined, and aortic wall thickness measures were taken. Bland-Altman plots and Passing-Bablock regression analyses were conducted to evaluate the correlation between the values. Results: pc-CT scan mean measurements were 1.05 and 1.69 mm, minimum/maximum, respectively. Mean minimum/maximum histology measurements were 1.66 and 2.82 mm, respectively. Bland Altman plots and Passing-Bablock regression analyses showed the absence of systematic bias and confirmed that measurement values were sufficiently similar (minimum −0.61 [CI 95% 0.16–1.38]; maximum −1.1 [0.73–2.99]). Conclusions: Despite results being merely preliminary, our study shows encouraging sufficiently similar results between aortic wall thickness measurements made with pc-CT scan and histology analyses.